• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部黏膜给予含 DNA 疫苗 pRSC-gD-IL-21 的纳米颗粒可在小鼠中预防单纯疱疹病毒 1 型的黏膜攻击。

An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.

机构信息

Department of Pathogenic Biology and Immunology, Medical School, Southeast University, Nanjing 210009, China.

出版信息

Vaccine. 2011 Feb 4;29(7):1455-62. doi: 10.1016/j.vaccine.2010.12.031. Epub 2010 Dec 24.

DOI:10.1016/j.vaccine.2010.12.031
PMID:21185849
Abstract

Herpes stromal keratitis (HSK) is a chronic inflammatory process caused by the infection of herpes simplex virus type 1 (HSV-1). Development of a HSV-1 vaccine is a priority because these infections are common and cannot be well prevented. It appears that the potential of nanocarriers in DNA vaccination will be required to augment the immune response to DNA vaccines. Therefore, in the study, nanoparticles Fe(3)O(4) coated with glutamic acid, DNA vaccine pRSC-gD-IL-21 and polyethylenimine were prepared and immunized in the mice by ocular mucosal administration. The immune responses and protection efficiency against HSV-1 challenge were also tested. The results showed that the nanoparticles containing DNA vaccine pRSC-gD-IL-21 induced mice to generate higher levels of specific neutralizing antibody, sIgA in tears, and IFN-γ, IL-4 in serum, and to enhance the cytotoxicities of NK cells and splenocytes as well as splenocyte proliferative response to glycoprotein D compared with those of the control mice. More importantly, the mice immunized with the experimental vaccine showed less HSK degree than that of the control mice after HSV-1 challenge of the murine ocular mucosa. In conclusion, an ocular mucosal administration of nanoparticles containing DNA vaccine confers strong specific immune responses and effective inhibition of HSK in a HSV-1 infected murine model.

摘要

单纯疱疹性基质角膜炎(HSK)是由单纯疱疹病毒 1 型(HSV-1)感染引起的慢性炎症过程。开发 HSV-1 疫苗是当务之急,因为这些感染很常见,而且无法很好地预防。似乎需要纳米载体来增强 DNA 疫苗的免疫反应,以增强对 DNA 疫苗的免疫反应。因此,在这项研究中,通过眼部黏膜给药,制备了用谷氨酸包被的纳米粒子 Fe(3)O(4)、DNA 疫苗 pRSC-gD-IL-21 和聚乙烯亚胺,并在小鼠中进行了免疫接种。还测试了针对 HSV-1 攻击的免疫反应和保护效率。结果表明,含有 DNA 疫苗 pRSC-gD-IL-21 的纳米粒子诱导小鼠产生更高水平的特异性中和抗体、泪液中的 sIgA 以及血清中的 IFN-γ、IL-4,并增强 NK 细胞和脾细胞的细胞毒性以及脾细胞对糖蛋白 D 的增殖反应,与对照组小鼠相比。更重要的是,与对照组小鼠相比,在 HSV-1 攻击小鼠眼黏膜后,用实验疫苗免疫的小鼠 HSK 程度较低。总之,眼部黏膜给予含有 DNA 疫苗的纳米粒子可在 HSV-1 感染的小鼠模型中引起强烈的特异性免疫反应并有效抑制 HSK。

相似文献

1
An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.眼部黏膜给予含 DNA 疫苗 pRSC-gD-IL-21 的纳米颗粒可在小鼠中预防单纯疱疹病毒 1 型的黏膜攻击。
Vaccine. 2011 Feb 4;29(7):1455-62. doi: 10.1016/j.vaccine.2010.12.031. Epub 2010 Dec 24.
2
Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.免疫接种表达单纯疱疹病毒 1 型 gD 和 IL-21 的 DNA 疫苗可预防小鼠疱疹性角膜炎。
Immunol Invest. 2011;40(3):265-78. doi: 10.3109/08820139.2010.534219. Epub 2011 Jan 4.
3
Topical Administration Is a Promising Inoculating Route versus Intramuscular Inoculation for the Nanoparticle-Carried DNA Vaccine to Prevent Corneal Infections.与肌肉注射相比,局部给药是纳米颗粒携带的DNA疫苗预防角膜感染的一种有前景的接种途径。
Ophthalmic Res. 2015;55(2):99-110. doi: 10.1159/000441898. Epub 2015 Dec 10.
4
Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.携带白细胞介素-12p35作为分子佐剂的重组单纯疱疹病毒1型(HSV-1)可增强针对眼部HSV-1攻击的保护性免疫反应。
J Virol. 2005 Mar;79(6):3297-308. doi: 10.1128/JVI.79.6.3297-3308.2005.
5
Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.鼻腔和皮肤给药的 IC31(®)-佐剂重组单纯疱疹病毒 2 糖蛋白 D 可预防生殖器疱疹。
Vaccine. 2012 Jun 19;30(29):4361-8. doi: 10.1016/j.vaccine.2012.02.019.
6
Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.编码gD或gD-IL-2的局部质粒DNA疫苗对疱疹性角膜炎的预防作用
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4209-15.
7
Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.用单纯疱疹病毒1型糖蛋白D衍生的“无症状”人CD8 + T细胞表位混合物进行治疗性免疫可减少潜伏感染的HLA转基因兔的自发性眼部排毒:与局部PD-1 + TIM-3 + CD8 +耗竭性T细胞的低频率相关。
J Virol. 2015 Jul;89(13):6619-32. doi: 10.1128/JVI.00788-15.
8
The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.一种编码单纯疱疹病毒1型(HSV-1)糖蛋白D的DNA疫苗在减轻角膜HSV-1攻击后眼部疾病严重程度方面的疗效。
Arch Virol. 2002 Sep;147(9):1747-59. doi: 10.1007/s00705-002-0830-6.
9
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.一种高效的单纯疱疹病毒1型疫苗可通过体液免疫阻断病毒发病机制并预防角膜免疫病理。
J Virol. 2016 May 12;90(11):5514-5529. doi: 10.1128/JVI.00517-16. Print 2016 Jun 1.
10
Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.白细胞介素-2的共表达增强了表达单纯疱疹病毒1型糖蛋白D的DNA疫苗的免疫效果。
Acta Virol. 2006;50(4):251-6.

引用本文的文献

1
Tackling cutaneous herpes simplex virus disease with topical immunomodulators-a call to action.使用局部免疫调节剂治疗皮肤单纯疱疹病毒疾病——行动呼吁
Clin Microbiol Rev. 2025 Mar 13;38(1):e0014724. doi: 10.1128/cmr.00147-24. Epub 2025 Feb 21.
2
Immune Response Elicited by Recombinant Adenovirus-Delivered Glycoprotein B and Nucleocapsid Protein UL18 and UL25 of HSV-1 in Mice.重组腺病毒递送单纯疱疹病毒1型糖蛋白B及核衣壳蛋白UL18和UL25在小鼠体内引发的免疫反应
Int J Mol Sci. 2024 Dec 16;25(24):13486. doi: 10.3390/ijms252413486.
3
Immunological Considerations for the Development of an Effective Herpes Vaccine.
开发有效疱疹疫苗的免疫学考量
Microorganisms. 2024 Sep 6;12(9):1846. doi: 10.3390/microorganisms12091846.
4
Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus.针对单纯疱疹病毒的新型治疗方法和疫苗的见解
Vaccines (Basel). 2023 Jan 31;11(2):325. doi: 10.3390/vaccines11020325.
5
An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections.深入了解针对单纯疱疹感染的当前治疗策略、其局限性以及疫苗技术的最新进展。
Vaccines (Basel). 2023 Jan 17;11(2):206. doi: 10.3390/vaccines11020206.
6
Mucosal vaccine delivery: A focus on the breakthrough of specific barriers.黏膜疫苗递送:聚焦特定屏障的突破
Acta Pharm Sin B. 2022 Sep;12(9):3456-3474. doi: 10.1016/j.apsb.2022.07.002. Epub 2022 Jul 6.
7
Nectin-1 and Non-muscle Myosin Heavy Chain-IIB: Major Mediators of Herpes Simplex Virus-1 Entry Into Corneal Nerves.Nectin-1与非肌肉肌球蛋白重链-IIB:单纯疱疹病毒-1进入角膜神经的主要介质
Front Microbiol. 2022 Feb 28;13:830699. doi: 10.3389/fmicb.2022.830699. eCollection 2022.
8
Developments in Vaccination for Herpes Simplex Virus.单纯疱疹病毒疫苗的进展
Front Microbiol. 2021 Dec 7;12:798927. doi: 10.3389/fmicb.2021.798927. eCollection 2021.
9
The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time.使用ICP0突变体0∆NLS和0∆RING的疫苗对眼部单纯疱疹病毒1型感染的效力持久性会随时间丧失。
Pathogens. 2021 Nov 12;10(11):1470. doi: 10.3390/pathogens10111470.
10
Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns.用冷冻硅化肿瘤细胞和病原体相关分子模式功能化的癌症疫苗。
Nat Biomed Eng. 2022 Jan;6(1):19-31. doi: 10.1038/s41551-021-00795-w. Epub 2021 Nov 1.